Target Gene/Pathway Pathway / Gene
Search results
| No. | KEGG PATHWAY On map, Yellow: Drug target, Red: All disease-related | KEGG GENES | KEGG DRUG | DrugBank | 指定難病告示番号 |
|---|---|---|---|---|---|
| 1 | Allograft rejection 💬 11 genes, 23 drugs (DrugBank) and 56 diseases |
IL5 1件: IL5 💬
|
Mepolizumab Mepolizumab 💬
| Mepolizumab | 044 4件: 44, 45, 98, 162 💬
|
| 2 | Allograft rejection 💬 11 genes, 23 drugs (DrugBank) and 56 diseases |
IL5 1件: IL5 💬
|
Reslizumab Reslizumab 💬
| Reslizumab | 044 2件: 44, 98 💬
|
| 3 | Asthma 💬 8 genes, 22 drugs (DrugBank) and 55 diseases |
IL5 1件: IL5 💬
|
Mepolizumab Mepolizumab 💬
| Mepolizumab | 044 4件: 44, 45, 98, 162 💬
|
| 4 | Asthma 💬 8 genes, 22 drugs (DrugBank) and 55 diseases |
IL5 1件: IL5 💬
|
Reslizumab Reslizumab 💬
| Reslizumab | 044 2件: 44, 98 💬
|
| 5 | Autoimmune thyroid disease 💬 22 genes, 15 drugs (DrugBank) and 35 diseases |
IL5 1件: IL5 💬
|
Mepolizumab Mepolizumab 💬
| Mepolizumab | 044 4件: 44, 45, 98, 162 💬
|
| 6 | Autoimmune thyroid disease 💬 22 genes, 15 drugs (DrugBank) and 35 diseases |
IL5 1件: IL5 💬
|
Reslizumab Reslizumab 💬
| Reslizumab | 044 2件: 44, 98 💬
|
| 7 | Cytokine-cytokine receptor interaction 💬 81 genes, 114 drugs (DrugBank) and 92 diseases |
IL5 1件: IL5 💬
|
Mepolizumab Mepolizumab 💬
| Mepolizumab | 044 4件: 44, 45, 98, 162 💬
|
| 8 | Cytokine-cytokine receptor interaction 💬 81 genes, 114 drugs (DrugBank) and 92 diseases |
IL5 1件: IL5 💬
|
Reslizumab Reslizumab 💬
| Reslizumab | 044 2件: 44, 98 💬
|
| 9 | Cytokine-cytokine receptor interaction 💬 81 genes, 114 drugs (DrugBank) and 92 diseases |
IL5RA 1件: IL5RA 💬
|
Benralizumab Benralizumab 💬
| Benralizumab | 044 5件: 44, 45, 98, 162, 299 💬
|
| 10 | Fc epsilon RI signaling pathway 💬 20 genes, 42 drugs (DrugBank) and 62 diseases |
IL5 1件: IL5 💬
|
Mepolizumab Mepolizumab 💬
| Mepolizumab | 044 4件: 44, 45, 98, 162 💬
|
| 11 | Fc epsilon RI signaling pathway 💬 20 genes, 42 drugs (DrugBank) and 62 diseases |
IL5 1件: IL5 💬
|
Reslizumab Reslizumab 💬
| Reslizumab | 044 2件: 44, 98 💬
|
| 12 | Hematopoietic cell lineage 💬 32 genes, 70 drugs (DrugBank) and 90 diseases |
IL5 1件: IL5 💬
|
Mepolizumab Mepolizumab 💬
| Mepolizumab | 044 4件: 44, 45, 98, 162 💬
|
| 13 | Hematopoietic cell lineage 💬 32 genes, 70 drugs (DrugBank) and 90 diseases |
IL5 1件: IL5 💬
|
Reslizumab Reslizumab 💬
| Reslizumab | 044 2件: 44, 98 💬
|
| 14 | Hematopoietic cell lineage 💬 32 genes, 70 drugs (DrugBank) and 90 diseases |
IL5RA 1件: IL5RA 💬
|
Benralizumab Benralizumab 💬
| Benralizumab | 044 5件: 44, 45, 98, 162, 299 💬
|
| 15 | IL-17 signaling pathway 💬 20 genes, 60 drugs (DrugBank) and 83 diseases |
IL5 1件: IL5 💬
|
Mepolizumab Mepolizumab 💬
| Mepolizumab | 044 4件: 44, 45, 98, 162 💬
|
| 16 | IL-17 signaling pathway 💬 20 genes, 60 drugs (DrugBank) and 83 diseases |
IL5 1件: IL5 💬
|
Reslizumab Reslizumab 💬
| Reslizumab | 044 2件: 44, 98 💬
|
| 17 | Inflammatory bowel disease 💬 24 genes, 43 drugs (DrugBank) and 64 diseases |
IL5 1件: IL5 💬
|
Mepolizumab Mepolizumab 💬
| Mepolizumab | 044 4件: 44, 45, 98, 162 💬
|
| 18 | Inflammatory bowel disease 💬 24 genes, 43 drugs (DrugBank) and 64 diseases |
IL5 1件: IL5 💬
|
Reslizumab Reslizumab 💬
| Reslizumab | 044 2件: 44, 98 💬
|
| 19 | Intestinal immune network for IgA production 💬 16 genes, 27 drugs (DrugBank) and 47 diseases |
IL5 1件: IL5 💬
|
Mepolizumab Mepolizumab 💬
| Mepolizumab | 044 4件: 44, 45, 98, 162 💬
|
| 20 | Intestinal immune network for IgA production 💬 16 genes, 27 drugs (DrugBank) and 47 diseases |
IL5 1件: IL5 💬
|
Reslizumab Reslizumab 💬
| Reslizumab | 044 2件: 44, 98 💬
|
| 21 | JAK-STAT signaling pathway 💬 58 genes, 91 drugs (DrugBank) and 96 diseases |
IL5 1件: IL5 💬
|
Mepolizumab Mepolizumab 💬
| Mepolizumab | 044 4件: 44, 45, 98, 162 💬
|
| 22 | JAK-STAT signaling pathway 💬 58 genes, 91 drugs (DrugBank) and 96 diseases |
IL5 1件: IL5 💬
|
Reslizumab Reslizumab 💬
| Reslizumab | 044 2件: 44, 98 💬
|
| 23 | JAK-STAT signaling pathway 💬 58 genes, 91 drugs (DrugBank) and 96 diseases |
IL5RA 1件: IL5RA 💬
|
Benralizumab Benralizumab 💬
| Benralizumab | 044 5件: 44, 45, 98, 162, 299 💬
|
| 24 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
IL5 1件: IL5 💬
|
Mepolizumab Mepolizumab 💬
| Mepolizumab | 044 4件: 44, 45, 98, 162 💬
|
| 25 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
IL5 1件: IL5 💬
|
Reslizumab Reslizumab 💬
| Reslizumab | 044 2件: 44, 98 💬
|
| 26 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
IL5RA 1件: IL5RA 💬
|
Benralizumab Benralizumab 💬
| Benralizumab | 044 5件: 44, 45, 98, 162, 299 💬
|
| 27 | T cell receptor signaling pathway 💬 34 genes, 46 drugs (DrugBank) and 80 diseases |
IL5 1件: IL5 💬
|
Mepolizumab Mepolizumab 💬
| Mepolizumab | 044 4件: 44, 45, 98, 162 💬
|
| 28 | T cell receptor signaling pathway 💬 34 genes, 46 drugs (DrugBank) and 80 diseases |
IL5 1件: IL5 💬
|
Reslizumab Reslizumab 💬
| Reslizumab | 044 2件: 44, 98 💬
|
| 29 | Th1 and Th2 cell differentiation 💬 33 genes, 37 drugs (DrugBank) and 70 diseases |
IL5 1件: IL5 💬
|
Mepolizumab Mepolizumab 💬
| Mepolizumab | 044 4件: 44, 45, 98, 162 💬
|
| 30 | Th1 and Th2 cell differentiation 💬 33 genes, 37 drugs (DrugBank) and 70 diseases |
IL5 1件: IL5 💬
|
Reslizumab Reslizumab 💬
| Reslizumab | 044 2件: 44, 98 💬
|